Medicine & Life Sciences
EphA2 Receptor
97%
Pharmaceutical Preparations
37%
Industry
36%
United States Food and Drug Administration
33%
Neoplasms
32%
Biological Products
30%
Drug Approval
28%
Drug Discovery
27%
Tyrosine
25%
Biotechnology
23%
Drug Development
23%
Ovarian Neoplasms
22%
Cadherins
22%
Communicable Diseases
22%
Growth
21%
Breast Neoplasms
20%
Antibodies
19%
Phosphorylation
19%
Ligands
19%
Integrins
19%
Epithelial Cells
18%
Phosphotransferases
17%
Protein-Tyrosine Kinases
17%
Cell Adhesion
17%
Prostatic Intraepithelial Neoplasia
16%
Antiviral Agents
16%
etaracizumab
16%
Monoclonal Antibodies
15%
Inventors
13%
Proteins
13%
Therapeutics
13%
Entrepreneurship
13%
Organizations
11%
Carcinoma
11%
Human Influenza
10%
Virus Diseases
10%
Ebolavirus
10%
Breast
10%
Viruses
10%
Receptor Protein-Tyrosine Kinases
10%
In Vitro Techniques
9%
Genes
9%
FGI 103
9%
Private Sector
9%
Epitopes
9%
Histocompatibility Antigens Class II
8%
Prostatic Neoplasms
8%
Eph Family Receptors
8%
NIH 3T3 Cells
8%
Tamoxifen
8%
Ephrins
8%
Public Health
8%
varespladib methyl
8%
Rift Valley fever virus
8%
Epithelium
8%
T-Lymphocytes
8%
Vaccines
8%
Pandemics
7%
Survival
7%
Orphan Drug Production
7%
Adenocarcinoma
7%
Mitogen-Activated Protein Kinases
7%
Adherens Junctions
7%
Cell Line
7%
Neoplasm Metastasis
7%
Renal Cell Carcinoma
7%
ras Proteins
7%
Drug Industry
7%
Infections
7%
Nervous System Diseases
7%
Focal Adhesion Protein-Tyrosine Kinases
7%
HIV
7%
Filoviridae Infections
7%
Estrogens
7%
Tsg101 protein
6%
Public Sector
6%
HIV-1
6%
Lung Neoplasms
6%
Prostate
6%
Cardiovascular Diseases
6%
Acquired Immunodeficiency Syndrome
6%
Melanoma
6%
Focal Adhesions
6%
Orthobunyavirus
6%
Bunyaviridae
6%
Intellectual Property
6%
Phenotype
5%
Farnesyltranstransferase
5%
Progranulins
5%
Carcinogenesis
5%
G-Protein-Coupled Receptors
5%
Ethacrynic Acid
5%
Drug Delivery Systems
5%
Technology
5%
Fibronectins
5%
Phosphotyrosine
5%
Catenins
5%
Phosphoric Monoester Hydrolases
5%
Bispecific Antibodies
5%
Cell Movement
5%
Chemical Compounds
Molecular Entity
100%
Drug
55%
Industry
25%
Biotechnology
21%
Pharmaceutical
20%
Tyrosine
16%
Orphan Drug
14%
Protein
10%
Time
8%
Disorder
8%
Molecule
7%
Pharmaceutical Industry
7%
Anti Human Immunodeficiency Virus Agent
5%
Taxane
5%
Antiapoptotic
5%
Antiviral Drug
5%
Pipeline
5%
Silencing RNA
5%